Drug Shortage Report for DOCETAXEL INJECTION USP

Last updated on 2020-03-05 History
Report ID 103614
Drug Identification Number 02361957
Brand name DOCETAXEL INJECTION USP
Common or Proper name Docetaxel Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DOCETAXEL
Strength(s) 10.0MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 16mL vial
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-31
Estimated end date 2020-03-13
Actual end date 2020-03-04
Shortage status Resolved
Updated date 2020-03-05
Company comments Other presentations remain available.
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2020-03-05 English Compare
v11 2020-03-04 French Compare
v10 2020-03-04 English Compare
v9 2020-02-26 French Compare
v8 2020-02-26 English Compare
v7 2020-02-10 French Compare
v6 2020-02-10 English Compare
v5 2020-02-01 English Compare
v4 2020-01-31 French Compare
v3 2020-01-31 English Compare
v2 2020-01-20 French Compare
v1 2020-01-20 English Compare